Performance Enhancing Drugs Market Research Report: By Types (Ergogenic Aids, Nootropic), By Products (Pills, Injections, Patches), By End Users (Athletes, Body Builders, Students, Militaries), and Others- Global Forecast Till 2023
Performance Enhancing Drugs Market – Segmentation
The global Performance Enhancing Drugs Market Statistics is segmented on the basis of types, products, and end users.
On the basis of types, the market is segmented into ergogenic aids, nootropic, and others. The ergogenic aids segment by types is sub-segmented into anabolic steroids, dehydroepiandrosterone (DHEA), human growth hormone, and others. The nootropic segment by types is further segmented into racetams, ampakines, choline & acetylcholine intermediates, others.
On the basis of the products, the market is categorised into pills, injections, patches, and others
On the basis of end users, the market is segmented into athletes, body builders, students, militaries, and others.
Performance Enhancing Drugs Market – Competitive Analysis
As the market seems to be attractive, growing and profitable, at the same time market has witnessed intense rivalry among existing competitors. Many new entrants expected to enter into Performance Enhancing Drugs market. There are many big players in the Performance Enhancing Drugs market such as: Taj Pharmaceuticals Limited. (India), Balkan Pharmaceuticals. (Europe), Bayer AG (Europe), AstraZeneca (Europe), Novo Nordisk A/S (Europe), BrainAlert, LLC (U.S.), Douglas Laboratories. (U.S.), Onnit Labs, LLC. (U.S.), Eli Lilly and Company. (U.S.)
Performance Enhancing Drugs – Market Overview
Performance enhancing drugs are chemical agents designed to provide an advantage in athletic performance. Muscle enlargement, increased blood’s oxygen carrying capacity are some of the effects induced by the consumption of the performance enhancing drugs. Growing use of the anabolic steroids by athletes, increasing use of steroids for the treatment of medical conditions such as, pain management, anaemia, and certain kinds of breast cancer besides others is expected to fuel the market growth.
Now there is new horizon & huge untapped market have been identified for performance enhancing drugs, as the drugs can be use by army to create an army of ‘super soldiers. SOCOM wants to use performance-enhancing drugs to create an army of ‘super soldiers.
U.S. Special Operations Command is weighing the use of nutritional supplements or even performance-enhancing drugs to push the abilities and endurance of its forces beyond current human limits, according to a report from defence news.
One goal of the research to develop what Defence news referred to as “super soldiers” would be to expand troops’ ability to operate in places not well suited for human’s high altitudes or underwater in particular.
Performance Enhancing Drugs Market – Regional Analysis
The Americas dominates the global performance enhancing drugs market owing to the presence of well-developed economies with high per capita income within the region like the U.S. & Canada. This Increasing prevalence of Brest cancer will boost the market growth, as anabolic steroids can be for the treatment of certain types of breast cancer.
Europe is the second largest market for performance enhancing drug market, which is followed by Asia Pacific. Availability of funds for research and development & increasing acceptance of the performance enhancing drugs within the region likely to boost the market.
Asia Pacific is the fastest growing region for the market due to the growing awareness of the performance enhancing drugs, continuously developing economies & presence of huge opportunity in the market.
On the other hand, the Middle East & Africa owns the least share of the global performance enhancing drugs market due to presence of poor economy, especially, in Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector & huge healthcare expenditure.
Get More Reports for Pharmaceutical at https://www.marketresearchfuture.com/categories/pharmaceutical-market-report
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312